Stock NGEN NERVGEN PHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. NervGen Pharma Corp.

Equities

NGEN

CA64082X2032

Delayed Toronto S.E.
Other stock markets
 11:06:08 2024-04-29 am EDT 		5-day change 1st Jan Change
2.06 CAD -2.37% Intraday chart for NervGen Pharma Corp. -3.29% -23.70%
Apr. 17 NervGen Reports FY 2023 Net Loss of $0.38 Per Share, Provides Operations Update MT
Apr. 17 NervGen Pharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NGEN Stock
  4. News NervGen Pharma Corp.
  5. Analyst Reco.